22 Mar,2024
BY : Maverick Braxton
0 Comments
The United States Food and Drug Administration (FDA) has recently taken a significant step in the battle against COVID-19 by announcing the clearance of the first over-the-counter (OTC) rapid antigen test for COVID-19. This noteworthy development introduces the Flowflex COVID-19 Antigen Home Test, innovatively developed by ACON Laboratories, as a reliable, accessible testing option for the general public. The test, having successfully navigated the traditional FDA premarket review pathway, emerges as the second at-home COVID-19 test to achieve this feat. Notably, this clearance is not merely a routine authorization; it signals a remarkable advancement in the field of diagnostic tools, especially in the context of infectious diseases.
LATEST POST
Frequently Asked Questions About Ezetimibe and Cholesterol Management
6 May 2023 | 05:55 AM
Spinach: The Natural Dietary Supplement You've Been Searching For
15 May 2023 | 09:33 AM
Mefenamic acid and cancer: potential benefits and risks
1 Aug 2023 | 23:36 PM
The role of hair care products in causing and preventing hair loss
13 Jun 2023 | 00:09 AM
Flurbiprofen: A Comprehensive Guide to Its Uses and Benefits
2 Jun 2023 | 17:52 PM
Write a comment